Divis Laboratories Ltd reported 6.17B in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Alaunos Therapeutics USD -7949000 715K Dec/2023
Aurobindo Pharma INR 10.94B 2.53B Jun/2025
Avita Medical AUD -10272000 22.56M Dec/2024
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Divis Laboratories Ltd 6.17B 2.48B Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Lupin INR 13.42B 4.62B Jun/2025
Moderna USD -817000000 146M Jun/2025
Organon & Co USD 360M 135M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Tectonic Therapeutic USD -22332000 8.34M Jun/2025
Tilray USD -42218000 5.65M Nov/2024
Viatris USD 185.4M 628M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025